Close Menu

NEW YORK (GenomeWeb) – An Australian research team has proposed that methylation landscape shifts, and corresponding physical and chemical changes to DNA, may serve as the basis for an assay for multiple cancer types.

"Virtually every piece of cancerous DNA we examined had this highly predictable pattern," corresponding author Matt Trau, a researcher with the University of Queensland's Center for Personalized Nanomedicine, said in a statement, calling it a "starting discovery."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).